Calabrese et al. proposed that mTOR alterations might contribute to the synaptic dysfunctions that characterize several psychiatric diseases and that the mTOR pathway might represent a potential target for pharmacological intervention [10]. This evidence concerns the gene MTOR and psychiatric disorder.